|Bid||7.60 x 0|
|Ask||8.05 x 0|
|Day's range||7.55 - 7.85|
|52-week range||6.15 - 13.80|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||08 May 2023 - 12 May 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Evolus, Inc. (EOLS) delivered earnings and revenue surprises of -14.29% and 0.39%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
NEWPORT BEACH, Calif., March 08, 2023--Evolus reports financial results for the fourth quarter and full year ended December 31, 2022 and provides a business update
NEWPORT BEACH, Calif., February 28, 2023--Evolus announces that members of its management team will be participating in the Barclays Global Healthcare Conference in Miami Beach, Florida.